These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29312802)

  • 1. EGFRwt/vIII-PKM2-β-catenin cascade affects proliferation and chemo-sensitivity in head and neck squamous cell carcinoma.
    Jing C; Qu X; Li Z; Wu C; Zhao M; Wang Y; Sun S; Zhang S; Chen J; Qiao Y; Hu X; Yao X; Jin R; Wang X; Zhang L; Zhou X
    Am J Cancer Res; 2017; 7(12):2491-2502. PubMed ID: 29312802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of β-catenin in cisplatin resistance, relapse and prognosis of head and neck squamous cell carcinoma.
    Roy S; Kar M; Roy S; Saha A; Padhi S; Banerjee B
    Cell Oncol (Dordr); 2018 Apr; 41(2):185-200. PubMed ID: 29243047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4.
    Lee SH; Koo BS; Kim JM; Huang S; Rho YS; Bae WJ; Kang HJ; Kim YS; Moon JH; Lim YC
    J Pathol; 2014 Sep; 234(1):99-107. PubMed ID: 24871033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.
    Sok JC; Coppelli FM; Thomas SM; Lango MN; Xi S; Hunt JL; Freilino ML; Graner MW; Wikstrand CJ; Bigner DD; Gooding WE; Furnari FB; Grandis JR
    Clin Cancer Res; 2006 Sep; 12(17):5064-73. PubMed ID: 16951222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediation of PKM2-dependent glycolytic and non-glycolytic pathways by ENO2 in head and neck cancer development.
    Gao L; Yang F; Tang D; Xu Z; Tang Y; Yang D; Sun D; Chen Z; Teng Y
    J Exp Clin Cancer Res; 2023 Jan; 42(1):1. PubMed ID: 36588153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STOML2 as a novel prognostic biomarker modulates cell proliferation, motility and chemo-sensitivity via IL6-Stat3 pathway in head and neck squamous cell carcinoma.
    Qu H; Jiang W; Wang Y; Chen P
    Am J Transl Res; 2019; 11(2):683-695. PubMed ID: 30899371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.
    Chen YL; Song JJ; Chen XC; Xu W; Zhi Q; Liu YP; Xu HZ; Pan JS; Ren JL; Guleng B
    World J Gastroenterol; 2015 Aug; 21(30):9093-102. PubMed ID: 26290635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation.
    Li Z; Yang Z; Passaniti A; Lapidus RG; Liu X; Cullen KJ; Dan HC
    Oncotarget; 2016 May; 7(22):31892-906. PubMed ID: 26895469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare occurrence of EGFRvIII deletion in head and neck squamous cell carcinoma.
    Khattri A; Zuo Z; Brägelmann J; Keck MK; El Dinali M; Brown CD; Stricker T; Munagala A; Cohen EE; Lingen MW; White KP; Vokes EE; Seiwert TY
    Oral Oncol; 2015 Jan; 51(1):53-8. PubMed ID: 25255959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor variant III in head and neck squamous cell carcinoma is not relevant for targeted therapy and irradiation.
    Thomas Koch D; Pickhard A; Gebel L; Buchberger AMS; Bas M; Mogler C; Reiter R; Piontek G; Wirth M
    Oncotarget; 2017 May; 8(20):32668-32682. PubMed ID: 28427242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapeutic alteration of β-catenin and c-kit expression by imatinib in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro.
    Schultz JD; Sommer JU; Hoedt S; Erben P; Hofheinz RD; Faber A; Thorn C; Hörmann K; Sauter A
    Oncol Rep; 2012 Jan; 27(1):270-80. PubMed ID: 21993766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor (EGF) receptor-ligand based molecular staging predicts prognosis in head and neck squamous cell carcinoma partly due to deregulated EGF- induced amphiregulin expression.
    Gao J; Ulekleiv CH; Halstensen TS
    J Exp Clin Cancer Res; 2016 Sep; 35(1):151. PubMed ID: 27669890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas.
    Szabó B; Nelhubel GA; Kárpáti A; Kenessey I; Jóri B; Székely C; Peták I; Lotz G; Hegedus Z; Hegedus B; Füle T; Döme B; Tímár J; Tóvári J
    Oral Oncol; 2011 Jun; 47(6):487-96. PubMed ID: 21498106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin D1-induced proliferation is independent of beta-catenin in head and neck cancer.
    Sales KU; Giudice FS; Castilho RM; Salles FT; Squarize CH; Abrahao AC; Pinto DS
    Oral Dis; 2014 Apr; 20(3):e42-8. PubMed ID: 23730900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor-induced pyruvate dehydrogenase kinase 1 expression enhances head and neck squamous cell carcinoma metastasis
    Hsu JY; Chang JY; Chang KY; Chang WC; Chen BK
    FASEB J; 2017 Oct; 31(10):4265-4276. PubMed ID: 28596235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC).
    Zhang F; Li Y; Zhang H; Huang E; Gao L; Luo W; Wei Q; Fan J; Song D; Liao J; Zou Y; Liu F; Liu J; Huang J; Guo D; Ma C; Hu X; Li L; Qu X; Chen L; Yu X; Zhang Z; Wu T; Luu HH; Haydon RC; Song J; He TC; Ji P
    Oncotarget; 2017 Feb; 8(8):12968-12982. PubMed ID: 28099902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LINC00958-MYC positive feedback loop modulates resistance of head and neck squamous cell carcinoma cells to chemo- and radiotherapy in vitro.
    Huang S; Zhan Z; Li L; Guo H; Yao Y; Feng M; Deng J; Xiong J
    Onco Targets Ther; 2019; 12():5989-6000. PubMed ID: 31413594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
    Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS
    Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Deoxy-d-glucose Suppresses the In Vivo Antitumor Efficacy of Erlotinib in Head and Neck Squamous Cell Carcinoma Cells.
    Sobhakumari A; Orcutt KP; Love-Homan L; Kowalski CE; Parsons AD; Knudson CM; Simons AL
    Oncol Res; 2016; 24(1):55-64. PubMed ID: 27178822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer.
    Li Z; Liao J; Yang Z; Choi EY; Lapidus RG; Liu X; Cullen KJ; Dan H
    Br J Cancer; 2019 Feb; 120(3):306-316. PubMed ID: 30585254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.